Media Coverage

Our commercial intelligence and analysis are used by the Financial Times, the Wall Street Journal, Forbes, Nature, and Reuters, among others.

Take a look at the latest Evaluate and Evaluate Vantage coverage. To learn more about how we work with healthcare and business reporters worldwide, or if you are looking for specific data and expert insights to support a current story, please contact us at [email protected].

Latest Media Coverage

Nature Reviews Drug Discovery

Top companies and drugs by sales in 2020

Having supplanted Novartis as the biggest pharma company by prescription sales in 2019, Roche managed to hang onto the title in 2020.

Browse the archive

The Pharma Letter

Look back at pharma news to Aug 10

"MyoKardia’s success in a Phase II hypertrophic cardiomyopathy trial is likely spurring investor speculation that the group could be a target for its partner and investor…

Seeking Alpha

Rebiotix Tries To Get One Up Over Seres

"We're building on three successful phase IIs... they've had one phase II programme that failed, and they have no other ones. What they're choosing to do is really…

Seeking Alpha

Does Roche Have The Hemophilia X Factor?

"I think [Roche's (OTCQX:RHHBY) emicizumab has been shown to be that," Guy Young of the Children's Hospital Los Angeles tells EP Vantage."